Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12417307rdf:typepubmed:Citationlld:pubmed
pubmed-article:12417307lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:12417307lifeskim:mentionsumls-concept:C1415288lld:lifeskim
pubmed-article:12417307lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:12417307lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:12417307lifeskim:mentionsumls-concept:C0444669lld:lifeskim
pubmed-article:12417307lifeskim:mentionsumls-concept:C1513371lld:lifeskim
pubmed-article:12417307pubmed:issue2lld:pubmed
pubmed-article:12417307pubmed:dateCreated2002-11-5lld:pubmed
pubmed-article:12417307pubmed:abstractTextX-ray structures of the GluR2 ligand-binding core in complex with (S)-Des-Me-AMPA and in the presence and absence of zinc ions have been determined. (S)-Des-Me-AMPA, which is devoid of a substituent in the 5-position of the isoxazolol ring, only has limited interactions with the partly hydrophobic pocket of the ligand-binding site, and adopts an AMPA-like binding mode. The structures, in comparison with other agonist complex structures, disclose the relative importance of the isoxazolol ring and of the substituent in the 5-position for the mode of binding. A relationship appears to exist between the extent of interaction of the ligand with the hydrophobic pocket and the affinity of the ligand.lld:pubmed
pubmed-article:12417307pubmed:languageenglld:pubmed
pubmed-article:12417307pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:citationSubsetIMlld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417307pubmed:statusMEDLINElld:pubmed
pubmed-article:12417307pubmed:monthNovlld:pubmed
pubmed-article:12417307pubmed:issn0014-5793lld:pubmed
pubmed-article:12417307pubmed:authorpubmed-author:EgebjergJJlld:pubmed
pubmed-article:12417307pubmed:authorpubmed-author:LiljeforsTTlld:pubmed
pubmed-article:12417307pubmed:authorpubmed-author:KasperCClld:pubmed
pubmed-article:12417307pubmed:authorpubmed-author:KastrupJ SJSlld:pubmed
pubmed-article:12417307pubmed:authorpubmed-author:GouauxEElld:pubmed
pubmed-article:12417307pubmed:authorpubmed-author:MadyG EGElld:pubmed
pubmed-article:12417307pubmed:issnTypePrintlld:pubmed
pubmed-article:12417307pubmed:day6lld:pubmed
pubmed-article:12417307pubmed:volume531lld:pubmed
pubmed-article:12417307pubmed:ownerNLMlld:pubmed
pubmed-article:12417307pubmed:authorsCompleteYlld:pubmed
pubmed-article:12417307pubmed:pagination173-8lld:pubmed
pubmed-article:12417307pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:meshHeadingpubmed-meshheading:12417307...lld:pubmed
pubmed-article:12417307pubmed:year2002lld:pubmed
pubmed-article:12417307pubmed:articleTitleGluR2 ligand-binding core complexes: importance of the isoxazolol moiety and 5-substituent for the binding mode of AMPA-type agonists.lld:pubmed
pubmed-article:12417307pubmed:affiliationDepartment of Medicinal Chemistry, Royal Danish School of Pharmacy, Universitetsparken 2, Copenhagen, Denmark.lld:pubmed
pubmed-article:12417307pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12417307pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12417307pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417307lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417307lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417307lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417307lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417307lld:pubmed